CTRI/2024/03/064256尚未招募2 期
An Open Label Single Arm Clinical Study to Evaluate the Efficacy of Kalyanaka Ghrita Nasya and Saraswatharishtam in Chittodvega vis-a-vis Generalized Anxiety Disorder - NI
Dr. Sumayya Iqra0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Subjects with clinical features of Generalized anxiety disorder (Chittodvega) under DSM- V criteria
- •2. Subjects between the age group of 20 to 60 years irrespective of gender, caste, religion will be included.
- •3. Both fresh and treated cases will be taken for the study
- •Definition of fresh cases include freshly diagnosed and untreated case of generalized anxiety disorder (Chittodvega)
- •Definition of treated cases includes already diagnosed and treated cases of generalized anxiety disorder (Chittodvega) with flush out period of 7 days.
排除标准
- •1. Patients diagnosed with Schizophrenia, Bipolar disorder, OCD, PTSD
- •2. Patients with history of chronic drug abuse
- •3. Patients under any psychotropic medication
- •4. Pregnant and lactating women will be excluded from the study.
- •5. Patients with uncontrolled hypertension (blood pressure levels above the range of systolic-150, diastolic-100 mmHg) and uncontrolled diabetes (Random blood sugar level above 250 milligrams per deciliter)
- •6. Subjects unfit for intervention (nasya karma) will be excluded
研究者
相似试验
尚未招募
2 期
A Clinical Study to Evalaute the Effect of Bilvaphala majja Avaleha in the Management of Garbhini Chardi(Emesis Gravidarum)CTRI/2023/06/053804Dr Kanchana
尚未招募
2 期
The Safety and Efficacy of HQMZ111831 as a Lactation Support to feeding MothersCTRI/2019/09/021400The Himalaya Drug Company
招募中
不适用
Clinical Study To Evaluate The Efficacy AndSafety Of Psoramit Ointment In patients suffering from mild tomoderate PsoriasisCTRI/2019/09/021423The Himalaya Drug Company
尚未招募
2 期
The Single Arm Clinical Study To Evaluate The Effect Of Hingvadi Gutika In Udavarta YonivyapadaCTRI/2024/01/061928SANE GURUJI AROGYA KENDRA
已完成
4 期
To evaluate the safety & Efficacy of Baby shampoo in babies of 0 months to 36 monthsCTRI/2023/06/054326Emami Ltd.36
